HitGen (SHG: 688222)

OTHER
Chengdu, Sichuan, China
Website

HitGen Inc is engaged in drug research and development and provision of technical consultation, technology transfer, and technical services. The company uses DEL technology to provide research and development services for early drug discovery and transfer of new drug R&D projects.

Total Investments
0
Portfolio Companies
0
Exits
0
Funds
0
Investment Focus

View 5 investors free

Create a free account to unlock HitGen (SHG: 688222)'s AUM, portfolio companies, fund details, and deal history.

No credit card required